doi:10.19982/j.issn.1000-6621.20220015

Abstract

CLC Number:

R522
R551.2

Figures/Tables 1

References 15

[1]	李军, 牛挺. 恶性血液病合并活动性结核病的临床研究进展. 中华血液学杂志, 2013, 34(12):1076-1079. doi: 10.3760/cma.j.issn.0253-2727.2013.12.020. doi: 10.3760/cma.j.issn.0253-2727.2013.12.020
[2]	李军, 蒋孟, 羊裔明, 等. 白血病合并活动性结核病44例临床研究——单中心报告. 中华血液学杂志, 2013, 34(7):572-577. doi: 10.3760/cma.j.issn.0253-2727.2013.07.003. doi: 10.3760/cma.j.issn.0253-2727.2013.07.003
[3]	Hirasaki S, Koide N, Ogawa H, et al. Active intestinal tuberculosis with esophageal candidiasis due to idiopathic CD4(+) T-lymphocytopenia in an elderly woman. J Gastroenterol, 2000, 35(1):47-51. doi: 10.1007/pl00009975. doi: 10.1007/pl00009975 pmid: 10632541
[4]	Chen CY, Sheng WH, Cheng A, et al. Clinical characteristics and outcomes of Mycobacterium tuberculosis disease in adult patients with he matological malignancies. BMC Infect Dis, 2011, 11:324. doi: 10.1186/1471-2334-11-324. doi: 10.1186/1471-2334-11-324 URL
[5]	《中华传染病杂志》编辑委员会. 发热待查诊治专家共识. 中华传染病杂志, 2017, 35(11):641-655. doi: 10.3760/cma.j.issn.1000-6680.2017.11.001. doi: 10.3760/cma.j.issn.1000-6680.2017.11.001
[6]	马小军, 王爱霞, 邓国华, 等. 不明原因发热449例临床分析. 中华内科杂志, 2004, 43(9):682-685. doi: 10.3760/j.issn:0578-1426.2004.09.014. doi: 10.3760/j.issn:0578-1426.2004.09.014
[7]	Yamasue M, Komiya K, Usagawa Y, et al. Factors associated with false negative interferon-γ release assay results in patients with tuberculosis: A systematic review with meta-analysis. Sci Rep, 2020, 10(1):1607. doi: 10.1038/s41598-020-58459-9. doi: 10.1038/s41598-020-58459-9 pmid: 32005930
[8]	Hines MR, von Bahr Greenwood T, Beutel G, et al. Consensus-Based Guidelines for the Recognition, Diagnosis, and Management of Hemophagocytic Lymphohistiocytosis in Critically Ill Children and Adults. Crit Care Med. 2021. doi: 10.1097/CCM.0000000000005361. doi: 10.1097/CCM.0000000000005361
[9]	《中国防痨杂志》编委会, 中国医疗保健国际交流促进会结核病防治分会全国耐药结核病协作组. 耐药结核病化疗过程中药品不良反应处理的专家共识. 中国防痨杂志, 2019, 41(6):591-603. doi: 10.3969/j.issn.1000-6621.2019.06.003. doi: 10.3969/j.issn.1000-6621.2019.06.003
[10]	雷建平. 我国结核病化疗药物不良反应的防治现状与进展. 中国防痨杂志, 2014, 36(9):774-782. doi: 10.3969/j.issn.1000-6621.2014.09.006. doi: 10.3969/j.issn.1000-6621.2014.09.006
[11]	李慧, 田芝奥, 吴霞. 648例结核病患者抗结核药物所致不良反应及危险因素分析. 中国防痨杂志, 2017, 39(11):1241-1246. doi: 10.3969/j.issn.1000-6621.2017.11.018. doi: 10.3969/j.issn.1000-6621.2017.11.018
[12]	朱敏, 刘亚东, 赵茜, 等. 警惕抗结核药物引起血液系统的异常. 中国防痨杂志, 2004, 26(6):338-340. doi: 10.3969/j.issn.1000-6621.2004.06.006. doi: 10.3969/j.issn.1000-6621.2004.06.006
[13]	夏露, 李锋, 卢水华. 结核合并类白血病反应误诊为白血病一例. 中华传染病杂志, 2015, 33(10):632-633. doi: 10.3760/cma.j.issn.1000-6680.2015.10.011. doi: 10.3760/cma.j.issn.1000-6680.2015.10.011
[14]	王娟明. 急性粟粒型肺结核类白血病反应8例. 中华结核和呼吸杂志, 2001, 24(2):123. doi: 10.3760/j:issn:1001-0939.2001.02.020. doi: 10.3760/j:issn:1001-0939.2001.02.020
[15]	鲁进, 黄汉平. 重症肺结核病合并类白血病反应误诊分析报告1例. 中国医药科学, 2017, 7(18):254-256. doi: 10.3969/j.issn.2095-0616.2017.18.079. doi: 10.3969/j.issn.2095-0616.2017.18.079

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 1

References 15

Related Articles 4

Recommended Articles

Metrics

Comments

[1]	. [J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1115-1118.
[2]	Liu Qiliang, Li Yuejie, Lei Mei. Clinicopathological features of 13 cases cervical lymph node tuberculosis complicated with metastatic carcinoma [J]. Chinese Journal of Antituberculosis, 2023, 45(9): 891-896.
[3]	Senior Department of Tuberculosis, the th Medical Center of Chinese PLA General Hospital, Editorial Board of Chinese Journal of Antituberculosis, Tuberculosis Control Branch of China Intrnational Exchange and Promotive Association for Medical and Health Care. Expert consensus on the diagnosis and treatment of superficial lymph node tuberculosis [J]. Chinese Journal of Antituberculosis, 2023, 45(6): 531-542.
[4]	Wang Yuanzhi, Long Meizhen, Liu Yiduo, Zhou Xiangmei. Application value of Mycobacterium bovis lipopolysaccharide in the serological diagnosis of tuberculosis in animals [J]. Chinese Journal of Antituberculosis, 2023, 45(4): 401-405.